Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modulators of glucocorticoid receptor, AP-1, and/or NF-kappabeta activity and use thereof

Modulators of glucocorticoid receptor, AP-1, and/or NF-kappabeta activity and use thereof

US Patent 8222247 · Granted Jul 17, 2012

Estimated economic value: $44,953,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Display substrate having a blocking dam provided with at least one groove and ma2025
Pixel circuit, pixel driving method and display device2021
Pixel circuit, driving method thereof and display panel2021
Imidazopyridazine JAK3 inhibitors and their use for the treatment of inflammator2016
Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammator2015
Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammator2015
Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammator2015
Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammator2014
Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammator2014
Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use there2012
Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use there2012
Cyclopentathiophene modulators of the glucocorticoid receptor, AP-1, and/or NF-κ2012